Las dosis serán utilizadas para proteger a personal sanitario y evaluar la respuesta de Ervebo frente al virus Bundibugyo.

WHO experts say early evidence, including animal studies, suggests Ervebo could offer some protection—and the new trial will seek to establish whether that protection extends to…

Imunizante aprovado mira a cepa Zaire, não a Bundibugyo